The EPA oxylipin, 12-HEPE, directly regulates human platelet activityKrista Goerger, Michael Holinstat, Taekyu Lee et al.|Journal of Lipid Research|2025Cited by 7
12-Hepe Regulates the Antiplatelet Effects of Epa, the ω-3 Fatty AcidKrista Goerger, Michael Holinstat, Andrew Rickenberg et al.|Blood|2024Cited by 2
CS585 Demonstrates Favorable Selectivity and Sustained <i>In Vivo</i> Action in Preventing Platelet Activation and Thrombosis Compared to Existing IP Receptor AgonistsLivia Stanger, Michael Holinstat, Pooja Yalavarthi et al.|Blood|2023Cited by 0
Selectivity and Long Action of <i>In Vivo</i> Efficacy of CS585, a Novel Prostacyclin Receptor Agonist, Compared to FDA-Approved Prostacyclin Agonists Iloprost and Selexipag in the Prevention of ThrombosisLivia Stanger, Michael Holinstat, Björn Dahlöf et al.|Blood|2024Cited by 0